NTI — Neurotech International Income Statement
0.000.00%
Last trade - 00:00
- AU$91.76m
- AU$86.73m
- AU$1.25m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | AAS | AAS | AAS | AAS | AAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.254 | 0.082 | 0.206 | 0.608 | 1.25 |
Cost of Revenue | |||||
Gross Profit | -0.196 | 0.027 | 0.227 | 0.601 | 1.25 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5.05 | 1.37 | 7.65 | 3.97 | 9.05 |
Operating Profit | -4.8 | -1.29 | -7.45 | -3.36 | -7.79 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -4.8 | -1.71 | -7.43 | -3.36 | -7.79 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.8 | -1.71 | -7.43 | -3.36 | -7.79 |
Net Income Before Extraordinary Items | |||||
Net Income | -4.8 | -1.71 | -7.43 | -3.36 | -7.79 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.8 | -1.71 | -7.43 | -3.36 | -7.79 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.024 | -0.011 | -0.015 | -0.005 | -0.01 |